Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 15Observational 1

Sponsor

Cancer Type

CNS 4Gynecologic 3Other hematologic neoplasm 2Genitourinary 2Breast 2Thoracic 1Other 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 1332Carcinoma, Hepatocellular 784Stomach Neoplasms 721Pancreatic Neoplasms 704Colonic Neoplasms 534Rectal Neoplasms 472Esophageal Neoplasms 423Liver Neoplasms 320Neoplasms 264Breast Neoplasms 220Lung Neoplasms 188Gastrointestinal Neoplasms 164Cholangiocarcinoma 150Barrett Esophagus 116Prostatic Neoplasms 107Neoplasm Metastasis 105Ovarian Neoplasms 89Carcinoma, Non-Small-Cell Lung 80Anus Neoplasms 77Melanoma 72Esophageal Squamous Cell Carcinoma 71Head and Neck Neoplasms 70Disease 70Gastrointestinal Stromal Tumors 67Colorectal Neoplasms, Hereditary Nonpolyposis 67Biliary Tract Neoplasms 67Liver Cirrhosis 60Gallbladder Neoplasms 58Recurrence 57Uterine Cervical Neoplasms 56

Interventions

Folfox protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neurotoxicity Syndromes × Gastrointestinal × Clear all
NCT05494320 2022-08-09

the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin

Ain Shams University

Unknown
120 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡